Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Specific targeting of IgE has shown varying degrees of clinical benefit across different allergic conditions, including asthma, chronic spontaneous urticaria, atopic dermatitis, chronic rhinosinusitis with nasal polyps, food allergies, and eosinophilic esophagitis.
In recent years, it has been demonstrated that targeting IgE with antibodies offers a safe and effective treatment method. Although several anti-IgE antibodies are currently bein…